Free Access
Med Sci (Paris)
Volume 24, Number 8-9, Août-Septembre 2008
Page(s) 694 - 696
Section Nouvelles
Published online 15 August 2008
  1. Heinrich PC, Behrmann I, Muller-Newen G, et al. Interleukin-6-type cytokine signalling through the gp130/Jak/TAT pathway. Biochem J 1998; 334 : 297–314. [Google Scholar]
  2. Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 2003; 88 : 1721–6. [Google Scholar]
  3. Alberti L, Thomachot MC, Bachelot T, et al. IL-6 as an intracrine growth factor for renal carcinoma cell lines. Int J Cancer 2004; 111 : 653–61. [Google Scholar]
  4. Blay JY, Rossi JF, Wijdenes J, et al. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer 1997; 72 : 424–30. [Google Scholar]
  5. Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumour progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999; 19 : 1427–32. [Google Scholar]
  6. Gao SP, Kevin G. Mark KG, Leslie K. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest 2007; 117 : 3846–56. [Google Scholar]
  7. Sansone P, Storci G, Tavolari S. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007; 117 : 3988–4002 [Google Scholar]
  8. Wakeling AE. Inhibitors of growth factor signalling. Endocr Relat Cancer 2005; 12 (suppl 1) : S183–7. [Google Scholar]
  9. Ginestier C, Korkaya H, Dontu G, et al. La cellule souche cancéreuse : un pilote aux commandes du cancer du sein. Med Sci (Paris) 2007; 23 : 1133–9. [Google Scholar]
  10. Deugnier MA, Petit V, Taddéi-De La Hosseraye I, et al. Vers la caractérisation des cellules souches de la glande mammaire murine adulte. Med Sci (Paris) 2007; 23 : 1125–31. [Google Scholar]
  11. Sheridan C, Kishimoto H, Fuchs RK et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8 : R59. [Google Scholar]
  12. Haruki N, Kawaguchi KS, Eichenberger S, et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res 2005; 65 : 3555–61. [Google Scholar]
  13. Kamakura S, Oishi K, Yoshimatsu T, et al. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol 2004; 6 : 547–54. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.